下调和上调
调节性B细胞
白细胞介素10
癌症研究
生物
细胞
人口
免疫学
B细胞
免疫系统
癌症
医学
基因
抗体
遗传学
环境卫生
作者
Christos Xiao,Xiang‐Ming Lao,Minmin Chen,Ruixian Liu,Wei Yuan,Fang‐Zhu Ouyang,Dong‐Ping Chen,Xiaoyu Zhao,Qiyi Zhao,Xuefeng Li,Chuan-Lu Liu,Limin Zheng,Dong‐Ming Kuang
出处
期刊:Cancer Discovery
[American Association for Cancer Research]
日期:2016-02-29
卷期号:6 (5): 546-559
被引量:336
标识
DOI:10.1158/2159-8290.cd-15-1408
摘要
We identify a novel protumorigenic PD-1(hi) B-cell subset in human HCC that exhibits a phenotype distinct from that of peripheral regulatory B cells. TLR4-mediated BCL6 upregulation is critical for induction of PD-1(hi) B cells, which operate via IL10-dependent pathways upon interacting with PD-L1 to cause T-cell dysfunction and foster disease progression. Cancer Discov; 6(5); 546-59. ©2016 AACR.See related commentary by Ren et al., p. 477This article is highlighted in the In This Issue feature, p. 461.
科研通智能强力驱动
Strongly Powered by AbleSci AI